HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea flag South Korea · Delayed Price · Currency is KRW
19,000
+210 (1.12%)
Jun 5, 2025, 3:30 PM KST

HLB Pharmaceutical Market Cap

HLB Pharmaceutical has a market cap or net worth of 266.80 billion as of June 6, 2025. Its market cap has decreased by -37.70% in one year.

Market Cap
266.80B
Enterprise Value
n/a
Revenue
36.10B
Ranking
n/a
PE Ratio
564.48
Stock Price
19,000.00

Market Cap Chart

Since December 21, 2015, HLB Pharmaceutical's market cap has increased from 84.28B to 266.80B, an increase of 216.57%. That is a compound annual growth rate of 12.95%.

History

DateMarket Cap% Change
Jun 5, 2025266.80B-21.16%
Dec 30, 2024338.42B58.45%
Dec 28, 2023213.58B43.49%
Dec 29, 2022148.85B-21.48%
Dec 30, 2021189.57B-21.05%
Dec 30, 2020240.12B219.34%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Samsung Biologics 72.53T
Celltrion 34.68T
ALTEOGEN 19.69T
Yuhan 7,778.15B
SK Biopharmaceuticals 7,079.52B
HLB Co., Ltd. 6,860.00B
PharmaResearch 4,976.64B
LigaChem Biosciences 3,893.48B
Market Cap Rankings